DexCom , Inc. (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM) systems for diabetes management with a market capitalization of $34.8 billion, finds itself at a critical juncture as it ...

DexCom Q4 revenue rose 8% YoY to $1.11 billion, beating estimates of $1.104 billion. DexCom reaffirms 2025 revenue guidance at $4.60 billion vs. consensus of $4.61 billion. Get real-time earnings ...

My name is Abby, and I will be your conference operator today. At this time, I would like to welcome everyone to the Dexcom Inc. fourth quarter 2024 earnings release conference call. All lines ...

DexCom (NASDAQ:DXCM), known for its continuous glucose monitoring (CGM) systems, recently unveiled its Q4 2024 earnings report on Feb. 13, 2025. This release highlighted an 8% growth in revenue ...

Operating income (non-GAAP) decreased to $209.5 million from $242.7 million. DexCom reported mixed earnings, with revenue surpassing estimates but earnings per share falling short. DexCom ...

After-hours stock movements include GameStop (GME), Twilio (TWLO), and DexCom (DXCM). To watch more expert insights and analysis on the latest market action, check out more Asking for a Trend&nbsp ...